Rasagiline, a novel monoamine oxidase-B inhibitor with neuroprotective effects under ischemic conditions in PC12 cells
- 1 July 2000
- journal article
- research article
- Published by Wiley in Drug Development Research
- Vol. 50 (3-4) , 285-290
- https://doi.org/10.1002/1098-2299(200007/08)50:3/4<285::aid-ddr11>3.0.co;2-8
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Rasagiline, a monoamine oxidase-B inhibitor, protects NGF-differentiated PC12 cells against oxygen-glucose deprivationJournal of Neuroscience Research, 1999
- Pathobiology of ischaemic stroke: an integrated viewPublished by Elsevier ,1999
- Calcium: still center-stage in hypoxic-ischemic neuronal deathTrends in Neurosciences, 1995
- A tissue culture ischemic device to study eicosanoid release by pheochromocytoma PC12 culturesJournal of Neuroscience Methods, 1993
- Growth factors protect PC12 cells against ischemia by a mechanism that is independent of PKA, PKC, and protein synthesisJournal of Neuroscience, 1993
- Rescue of axotomized immature rat facial motoneurons by R(-)-deprenyl: stereospecificity and independence from monoamine oxidase inhibitionJournal of Neuroscience, 1993
- The Role of Glutamate Neurotoxicity in Hypoxic-Ischemic Neuronal DeathAnnual Review of Neuroscience, 1990
- Mechanism of Arachidonic Acid Liberation During Ischemia in Gerbil Cerebral CortexJournal of Neurochemistry, 1987
- CHANGES IN FREE FATTY ACIDS OF BRAIN BY DRUG‐INDUCED CONVULSIONS, ELECTROSHOCK AND ANAESTHESIAJournal of Neurochemistry, 1971
- Effects of ischemia and electroconvulsive shock on free fatty acid pool in the brainBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1970